Dexcom (DXCM) Payables (2011 - 2025)

Dexcom (DXCM) posted quarterly Payables of $1.2 billion for Q3 2025, little changed quarter-over-quarter from $1.2 billion in Q2 2025.

Dexcom (DXCM) Payables (2011 - 2025) Analysis & Trends

Dexcom (DXCM) has reported Payables for 6 consecutive years, with $1.2 billion the latest figure, recorded in Q3 2025.

In Q3 2025, Payables changed N/A year-over-year to $1.2 billion; the TTM figure through Sep 2025 stood at $1.2 billion (changed N/A YoY), while the FY2024 annual figure was $1.2 billion, changed N/A from the prior year.
Payables was little changed at $1.2 billion in Q3 2025 per DXCM's latest filing, from $1.2 billion in the prior quarter.
Across five years, Payables topped out at $1.2 billion in Q3 2025 and bottomed at $124.2 million in Q3 2023.
Historically, Payables has averaged $908.3 million across 4 years, with a median of $989.1 million in 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Abbott Laboratories	200.08 Bn	194.48 Bn	7.27 Bn	5.89 Bn
2	Stryker	129.71 Bn	126.23 Bn	4.50 Bn	2.00 Bn
3	Medtronic	120.07 Bn	110.85 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	74.08 Bn	73.54 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.51 Bn	32.56 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.03 Bn	31.92 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.51 Bn	23.19 Bn	4.55 Bn	2.51 Bn
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	587.50 Mn
10	Zimmer Biomet Holdings	19.37 Bn	18.96 Bn	1.54 Bn	352.40 Mn

Download Data